Phospholipase A2-Responsive Phosphate Micelle-Loaded UCNPs for Bioimaging of Prostate Cancer Cells

被引:38
|
作者
Sharipov, Mirkomil [1 ]
Tawfik, Salah M. [1 ]
Gerelkhuu, Zayakhuu [1 ]
Bui The Huy [1 ]
Lee, Yong-Ill [1 ]
机构
[1] Changwon Natl Univ, Dept Chem, Chang Won 641773, South Korea
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
基金
新加坡国家研究基金会;
关键词
DRUG-DELIVERY; POLYMERIC MICELLES; SURFACE; TUMOR; NANOPARTICLES; THERAPY; PROBE;
D O I
10.1038/s41598-017-16136-4
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We report the effective synthesis of biocompatible upconversion nanoparticles (UCNP)-loaded phosphate micelles and successful delivery of UCNPs to prostate cancer cells via secreted phospholipase A2 (sPLA-2) enzyme cleavage of the loaded micelles for the first time. The activity of the (sPLA-2) enzyme toward the synthesized micelles was investigated and confirmed by LC-MS. TEM results showed that the micelles have a size distribution of 80 to 150 nm, whereas UCNP-loaded micelles range from 200 to 350 nm, indicating the successful loading of UCNPs. The selective release of UCNPs to prostate cancer cells rather than other cells, specifically cervical cancer cells, was observed and confirmed by a range of bioimaging studies. Moreover, cytotoxicity assays confirmed the biocompatibility of the UCNP-loaded micelles.
引用
收藏
页数:9
相关论文
共 33 条
  • [1] Phospholipase A2-Responsive Phosphate Micelle-Loaded UCNPs for Bioimaging of Prostate Cancer Cells
    Mirkomil Sharipov
    Salah M. Tawfik
    Zayakhuu Gerelkhuu
    Bui The Huy
    Yong-Ill Lee
    Scientific Reports, 7
  • [2] Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2 responsive liposome in prostate cancer
    Mock, J. N.
    Costyn, L. J.
    Wilding, S. L.
    Arnoldz, R. D.
    Cummings, B. S.
    INTEGRATIVE BIOLOGY, 2013, 5 (01) : 172 - 182
  • [3] Role of the Phospholipase A2 Receptor in Liposome Drug Delivery in Prostate Cancer Cells
    Quach, N. D.
    Mock, J. N.
    Scholpa, N. E.
    Eggert, M. W.
    Payre, C.
    Lambeau, G.
    Arnold, R. D.
    Cummings, B. S.
    MOLECULAR PHARMACEUTICS, 2014, 11 (10) : 3443 - 3451
  • [4] AKT and Cytosolic Phospholipase A2α form a Positive Loop in Prostate Cancer Cells
    Hua, Sheng
    Vignarajan, Soma
    Yao, Mu
    Xie, Chanlu
    Sved, Paul
    Dong, Qihan
    CURRENT CANCER DRUG TARGETS, 2015, 15 (09) : 781 - 791
  • [5] Activation of phospholipase D2 results in production of lysophosphatidic acid in human prostate cancer cells
    Xie, Y
    Meier, KE
    FASEB JOURNAL, 2000, 14 (08): : A1466 - A1466
  • [6] Therapeutic effect and metabolic fingerprinting of triple-negative breast cancer cells following exposure to a novel pH-responsive, gambogic acid-loaded micelle
    Da, Mengting
    Li, Su
    Yang, Rui
    Jia, Zhen
    Ma, Yulian
    Qi, Fengxian
    Zhao, Jiuda
    Shen, Guoshuang
    Chen, Daozhen
    NANOTECHNOLOGY, 2024, 35 (11)
  • [7] Loss of PTEN stabilizes the lipid modifying enzyme cytosolic phospholipase A2a via AKT in prostate cancer cells
    Vignarajan, Soma
    Xie, Chanlu
    Yao, Mu
    Sun, Yuting
    Simanainen, Ulla
    Sved, Paul
    Liu, Tao
    Dong, Qihan
    ONCOTARGET, 2014, 5 (15) : 6289 - 6299
  • [8] Targeting of cytosolic phospholipase A2α impedes cell cycle re-entry of quiescent prostate cancer cells
    Yao, Mu
    Xie, Chanlu
    Kiang, Mei-Yee
    Teng, Ying
    Harman, David
    Tiffen, Jessamy
    Wang, Qian
    Sved, Paul
    Bao, Shisan
    Witting, Paul
    Holst, Jeff
    Dong, Qihan
    ONCOTARGET, 2015, 6 (33) : 34458 - 34474
  • [9] Cytosolic phospholipase A2α sustains pAKT, pERK and AR levels in PTEN-null/mutated prostate cancer cells
    Hua, Sheng
    Yao, Mu
    Vignarajan, Soma
    Witting, Paul
    Hejazi, Leila
    Gong, Zhen
    Teng, Ying
    Niknami, Marzieh
    Assinder, Stephen
    Richardson, Des
    Dong, Qihan
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2013, 1831 (06): : 1146 - 1157
  • [10] Host cell expression of calcium-independent phospholipase A2 (iPLA2) is required for tumorigenesis and metastasis of prostate cancer cells
    Singh, Lisam S.
    Zhang, Hong
    Li, Hui
    Wang, Dongmei
    Zhao, Zhenwen
    Kirmani, Kashif
    Xu, Yan
    CLINICAL & EXPERIMENTAL METASTASIS, 2009, 26 (07) : 902 - 903